Applied Therapeutics Inc (NASDAQ: APLT) on Friday, soared 3.83% from the previous trading day, before settling in for the closing price of $9.27. Within the past 52 weeks, APLT’s price has moved between $1.79 and $10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 7.56%. With a float of $86.88 million, this company’s outstanding shares have now reached $116.36 million.
The firm has a total of 25 workers. Let’s measure their productivity. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Applied Therapeutics Inc is 25.33%, while institutional ownership is 86.86%. The most recent insider transaction that took place on Aug 22 ’24, was worth 78,880. In this transaction Chief Financial Officer of this company sold 13,530 shares at a rate of $5.83, taking the stock ownership to the 277,911 shares. Before that another transaction happened on Aug 22 ’24, when Company’s Chief Medical Officer sold 22,681 for $5.83, making the entire transaction worth $132,230. This insider now owns 986,853 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.33 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.2) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.56% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Applied Therapeutics Inc (APLT) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 109.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.48 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Analysing the last 5-days average volume posted by the [Applied Therapeutics Inc, APLT], we can find that recorded value of 1.45 million was lower than the volume posted last year of 1.83 million. As of the previous 9 days, the stock’s Stochastic %D was 49.51%. Additionally, its Average True Range was 0.62.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 84.18%, which indicates a significant increase from 52.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.06% in the past 14 days, which was lower than the 105.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.59, while its 200-day Moving Average is $6.10. Now, the first resistance to watch is $9.86. This is followed by the second major resistance level at $10.10. The third major resistance level sits at $10.55. If the price goes on to break the first support level at $9.17, it is likely to go to the next support level at $8.71. Now, if the price goes above the second support level, the third support stands at $8.48.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
Market capitalization of the company is 1.16 billion based on 116,356K outstanding shares. Right now, sales total 9,990 K and income totals -119,760 K. The company made 120 K in profit during its latest quarter, and -68,590 K in sales during its previous quarter.
